Brief: Anebulo Pharmaceuticals Reports Q3 Loss Per Share Of $0.08
11/05/2022 14:18
May 11 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O :
* ANEBULO PHARMACEUTICALS REPORTS THIRD QUARTER FISCAL YEAR
2022
FINANCIAL RESULTS AND RECENT UPDATES
* Q3 LOSS PER SHARE $0.08
* CASH AND CASH EQUIVALENTS WERE $16.5 MILLION AS OF MARCH
31,
2022
Source text for Eikon: ID:nBw6pkLZHa
Further company coverage: ANEB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anebulo Pharmaceuticals
See all newsAdvisory: Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn
Anebulo Pharmaceuticals Q2 net loss narrows
Brief: Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC
Anebulo Pharmaceuticals posts Q1 net loss
Brief: Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial Results